{"id":"W2954372606","doi":"10.1080/21678421.2019.1632346","title":"Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial","year":2019,"lang":"en","type":"article","venue":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Fundación Española para el Fomento de la Investigación de la Esclerosis Lateral Amiotrófica","keywords":"Medicine; Internal medicine; Clinical endpoint; Population; Amyotrophic lateral sclerosis; Placebo; Cohort; Riluzole; Tolerability; Randomized controlled trial; Oncology; Adverse effect; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001811973,0.001562933,0.003073758,0.0004902836,0.000424325,0.001206129,0.00095489,0.002249417,0.00498375],"category_scores_gemma":[0.001666872,0.0004088516,0.002342953,0.0003495407,0.0008594691,0.001225728,0.0003061193,0.002641515,0.0009875223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00110024,"about_ca_system_score_gemma":0.0009749171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008174186,"about_ca_topic_score_gemma":0.002130989,"domain_scores_codex":[0.9992243,0.0004321329,0.00005909264,0.00009573971,0.00006578675,0.000122959],"domain_scores_gemma":[0.9991068,0.0002442917,0.0001863683,0.00005142705,0.00007793705,0.000333147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9673674,0.002701352,0.0004887615,0.0009682307,0.001547911,0.00006777229,0.00003342437,0.0003594513,0.002199578,0.0001177505,0.001510967,0.02263726],"study_design_scores_gemma":[0.9380949,0.05679751,0.001781425,0.00006480448,0.0009134443,0.00006700752,0.00002265857,0.0004664732,0.0004465419,0.000143015,0.001180892,0.00002140294],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9579811,0.02811731,0.0006044472,0.002151179,0.001756875,0.003251758,0.001564341,0.0002743294,0.004298748],"genre_scores_gemma":[0.9808916,0.007420123,0.001161739,0.001894606,0.000879895,0.003024972,0.00167073,0.00003033477,0.003025894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00498375,"threshold_uncertainty_score":0.01667231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05266457784771603,"score_gpt":0.3135612327284365,"score_spread":0.2608966548807204,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}